oxalates has been researched along with Skin-Neoplasms* in 4 studies
1 trial(s) available for oxalates and Skin-Neoplasms
Article | Year |
---|---|
Double-blind study of variables influencing the clinical effect of Solcoderm.
Double-blind clinical studies of pairs of lesions were initiated to evaluate several components of Solcoderm treatment. The superiority of Solcoderm over plain nitric acid was as evident with plastic as with wooden applicators. A mixture of oxalic and nitric acid had effects similar to Solcoderm, while acetic and nitric acid was similar in effect to plain nitric acid. Topics: Acetates; Acetic Acid; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Copper; Dermatologic Agents; Double-Blind Method; Drug Combinations; Humans; Lactates; Nitrates; Nitric Acid; Oxalates; Oxalic Acid; Random Allocation; Skin Neoplasms | 1984 |
3 other study(ies) available for oxalates and Skin-Neoplasms
Article | Year |
---|---|
Oxalomalate reduces tumor progression in melanoma via ROS-dependent proapoptotic and antiangiogenic effects.
The potent cytotoxicity of reactive oxygen species (ROS) can cause various diseases, however, it may also serve as a powerful chemotherapeutic strategy capable of killing cancer cells. Oxalomalate (OMA, α-hydroxy-β-oxalosuccinic acid), a tricarboxylic acid intermediate, is a well-known competitive inhibitor of two classes of NADP Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Checkpoint Kinase 2; Isocitrate Dehydrogenase; Male; Melanoma; Mice; Neovascularization, Pathologic; Oxalates; Reactive Oxygen Species; Skin Neoplasms; Tumor Suppressor Protein p53 | 2019 |
The effect of melanin bleaching on immunohistochemical staining in heavily pigmented melanocytic neoplasms.
The accumulation of excessive amounts of melanin in melanocytic lesions can obscure cellular morphology and can further hinder immunocytochemical procedures. We have used a modification of the potassium permanganate/oxalic acid melanin-bleaching technique, involving much reduced bleaching times, in order to remove melanin granules prior to incubation with primary antibody. We have assessed a panel of antibodies applicable to the evaluation of melanocytic lesions and in addition have also assessed antibodies that may be more useful in research. The study attempts to determine which antigens may be affected by bleaching and which are not. Antigens S100, HMB 45, NKIC3, CD34, and L26 are relatively unaffected by this procedure. Factor-VIII-related antigen and vimentin and CD68 antigens produced enhanced staining. In contrast, antigens CD3, CD31, and CD45RO were abolished. In addition, smooth muscle actin and desmin antigens demonstrated considerable nonspecific background staining and were not reliable in this study. This technique demonstrates that a fairly wide range of antigens are preserved after bleaching and that distinction between melanocytes and melanophages can reliably be performed using the conventional immunocytochemical chromogen 3,3-diaminobenzidine and without the need for elaborate counterstaining. Topics: Actins; Antigens, CD; Antigens, CD20; Antigens, CD34; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; CD3 Complex; Desmin; Humans; Immunohistochemistry; Leukocyte Common Antigens; Melanins; Melanoma; Melanoma-Specific Antigens; Neoplasm Proteins; Oxalates; Oxidation-Reduction; Pigmentation; Platelet Endothelial Cell Adhesion Molecule-1; Potassium Permanganate; Reproducibility of Results; S100 Proteins; Sensitivity and Specificity; Skin; Skin Neoplasms; Vimentin; von Willebrand Factor | 1998 |
The effect of melanin pigment removal on the peroxidase-antiperoxidase immunoperoxidase technic.
With the increasing use of immunoperoxidase technics, it may be difficult to differentiate between the dark staining of 3,3'-diaminobenzidine (DAB) compound reaction product and melanin pigment. The latter may be particularly observed in skin. Samples of both normal skin and melanotic malignant melanoma were treated for the removal of melanin by standard technics both before and after a peroxidase-antiperoxidase (PAP) immunohistologic sequence. Many methods for the removal of melanin pigment resulted in diminished DAB staining intensity. Some also caused cellular disruption. However, the method of choice was found to be treatment with 0.25 g/dL potassium permanganate and 1 g/dL oxalic acid before the immunoperoxidase sequence. Topics: 3,3'-Diaminobenzidine; Humans; Immunoenzyme Techniques; Melanins; Melanoma; Oxalates; Oxalic Acid; Potassium Permanganate; Skin Neoplasms | 1987 |